Daliresp FDA Approved Drugs
DALIRESP [RoflumilastC17H14Cl2F2N2O3]
RX
- 500mcg (oral tablet)
Astrazeneca PharmsFeb 28, 2011
- Treatment to reduce the risk of copd exacerbations in patients with severe copd associated with chronic bronchitis and a history of exacerbations.
WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.